Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Walsh

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Journal of Affective Disorders|November 8, 2015
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labelingMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Psychopharmacology|February 6, 2016
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
International Journal of Geriatric Psychiatry|August 23, 2016
Inclusion/exclusion criteria in late life depression antidepressant efficacy trialsMark Zimmerman, Matthew D Multach, Heather L Clark, et al.
Journal of Affective Disorders|March 23, 2016
Variability in the substance use disorder exclusion criterion in antidepressant efficacy trialsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Mayo Clinic Proceedings|August 16, 2015
Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 13, 2026
How Do Patient Decision Aids Enable Purposeful Shared Decision-Making in Rheumatology? An Integrative ReviewBharat Kumar, Ibiyemi Oke, Ruoning Ni, et al.
CNS Drugs|August 20, 2016
The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 YearsMark Zimmerman, Carolina Guzman Holst, Heather L Clark, et al.
Novartis Foundation Symposium|July 8, 2005
Mapping autoimmune disease genes in humans: lessons from IBD and SLETimothy J Vyse, Angela M Richardson, Emily Walsh, et al.
Human Gene Therapy|December 29, 2021
Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat ModelRebecca Senter, Rogely Boyce, Marko Repic, et al.
Mycologia|January 30, 2026
Pleoscrubiaceae, a new family in Pleosporales (Dothideomycetes) from the Florida scrub ecosystemJing Luo, Alexis Faulborn, Aaron S David, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Journal of Affective Disorders|November 8, 2015
Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labelingMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Psychopharmacology|February 6, 2016
Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
International Journal of Geriatric Psychiatry|August 23, 2016
Inclusion/exclusion criteria in late life depression antidepressant efficacy trialsMark Zimmerman, Matthew D Multach, Heather L Clark, et al.
Journal of Affective Disorders|March 23, 2016
Variability in the substance use disorder exclusion criterion in antidepressant efficacy trialsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Mayo Clinic Proceedings|August 16, 2015
Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 YearsMark Zimmerman, Heather L Clark, Matthew D Multach, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 13, 2026
How Do Patient Decision Aids Enable Purposeful Shared Decision-Making in Rheumatology? An Integrative ReviewBharat Kumar, Ibiyemi Oke, Ruoning Ni, et al.
CNS Drugs|August 20, 2016
The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 YearsMark Zimmerman, Carolina Guzman Holst, Heather L Clark, et al.
Novartis Foundation Symposium|July 8, 2005
Mapping autoimmune disease genes in humans: lessons from IBD and SLETimothy J Vyse, Angela M Richardson, Emily Walsh, et al.
Human Gene Therapy|December 29, 2021
Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra Gene Therapy for Osteoarthritis Treatment, in a Rat ModelRebecca Senter, Rogely Boyce, Marko Repic, et al.
Mycologia|January 30, 2026
Pleoscrubiaceae, a new family in Pleosporales (Dothideomycetes) from the Florida scrub ecosystemJing Luo, Alexis Faulborn, Aaron S David, et al.
Pageof 7